175 related articles for article (PubMed ID: 33571012)
1. Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.
van Vucht N; Santiago R; Pressney I; Saifuddin A
Br J Radiol; 2021 Mar; 94(1119):20200710. PubMed ID: 33571012
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in-phase and opposed-phase T1W gradient echo and T2W fast spin echo dixon chemical shift imaging for the assessment of non-neoplastic, benign neoplastic and malignant marrow lesions.
Saifuddin A; Shafiq H; Malhotra K; Santiago R; Pressney I
Skeletal Radiol; 2021 Jun; 50(6):1209-1218. PubMed ID: 33196854
[TBL] [Abstract][Full Text] [Related]
3. In-phase and opposed-phase Dixon chemical shift imaging for the assessment of skeletal marrow lesions: comparison of measurements from longitudinal sequences to those from axial sequences.
Saifuddin A; Ali M; Santiago R; Pressney I
Br J Radiol; 2024 Mar; 97(1156):828-833. PubMed ID: 38321150
[TBL] [Abstract][Full Text] [Related]
4. Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation?
van Vucht N; Santiago R; Pressney I; Saifuddin A
Skeletal Radiol; 2020 Aug; 49(8):1269-1275. PubMed ID: 32198527
[TBL] [Abstract][Full Text] [Related]
5. Paediatric bone lesions: diagnostic accuracy of imaging correlation and CT-guided needle biopsy for differentiating benign from malignant lesions.
Vidoni A; Pressney I; Saifuddin A
Br J Radiol; 2021 Apr; 94(1120):20201234. PubMed ID: 33565896
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of hip pain in children referred to a specialist bone tumour service.
Choraria A; O'Donnell P; Saifuddin A
Br J Radiol; 2022 Jun; 95(1134):20211397. PubMed ID: 35343784
[TBL] [Abstract][Full Text] [Related]
7. Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine.
Douis H; Davies AM; Jeys L; Sian P
Eur Radiol; 2016 Apr; 26(4):932-40. PubMed ID: 26162578
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of In-Phase and Opposed-Phase Chemical-Shift Imaging for Differentiating Benign and Malignant Vertebral Marrow Lesions: A Meta-Analysis.
Suh CH; Yun SJ; Jin W; Park SY; Ryu CW; Lee SH
AJR Am J Roentgenol; 2018 Oct; 211(4):W188-W197. PubMed ID: 30160981
[TBL] [Abstract][Full Text] [Related]
9. Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.
Zajick DC; Morrison WB; Schweitzer ME; Parellada JA; Carrino JA
Radiology; 2005 Nov; 237(2):590-6. PubMed ID: 16244268
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience.
Kohl CA; Chivers FS; Lorans R; Roberts CC; Kransdorf MJ
Skeletal Radiol; 2014 Aug; 43(8):1079-84. PubMed ID: 24781818
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies.
Akman B; Ata Korkmaz HA; Sarı A
Turk J Med Sci; 2019 Apr; 49(2):644-652. PubMed ID: 30889945
[TBL] [Abstract][Full Text] [Related]
12. Pathological fracture in paediatric bone tumours and tumour-like lesions: A predictor of benign lesions?
Chaib B; Malhotra K; Khoo M; Saifuddin A
Br J Radiol; 2021 Sep; 94(1125):20201341. PubMed ID: 34319796
[TBL] [Abstract][Full Text] [Related]
13. Advanced MR imaging of bone marrow: quantification of signal alterations on T1-weighted Dixon and T2-weighted Dixon sequences in red marrow, yellow marrow, and pathologic marrow lesions.
Sasiponganan C; Yan K; Pezeshk P; Xi Y; Chhabra A
Skeletal Radiol; 2020 Apr; 49(4):541-548. PubMed ID: 31606776
[TBL] [Abstract][Full Text] [Related]
14. Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities?
Kumar NM; Ahlawat S; Fayad LM
Skeletal Radiol; 2018 Dec; 47(12):1661-1671. PubMed ID: 29936558
[TBL] [Abstract][Full Text] [Related]
15. Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions.
Schmeel FC; Luetkens JA; Wagenhäuser PJ; Meier-Schroers M; Kuetting DL; Feißt A; Gieseke J; Schmeel LC; Träber F; Schild HH; Kukuk GM
Eur Radiol; 2018 Jun; 28(6):2397-2405. PubMed ID: 29313118
[TBL] [Abstract][Full Text] [Related]
16. Value of opposed-phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions.
Zampa V; Cosottini M; Michelassi C; Ortori S; Bruschini L; Bartolozzi C
Eur Radiol; 2002 Jul; 12(7):1811-8. PubMed ID: 12111073
[TBL] [Abstract][Full Text] [Related]
17. Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
Hegde V; Burke ZDC; Park HY; Zoller SD; Johansen D; Kelley BV; Levine B; Motamedi K; Federman NC; Seeger LL; Nelson SD; Bernthal NM
Clin Orthop Relat Res; 2018 Mar; 476(3):568-577. PubMed ID: 29529643
[TBL] [Abstract][Full Text] [Related]
18. Focal nodular marrow hyperplasia: Imaging features of 53 cases.
Rajakulasingam R; Saifuddin A
Br J Radiol; 2020 Aug; 93(1112):20200206. PubMed ID: 32463293
[TBL] [Abstract][Full Text] [Related]
19. The role of chemical shift magnetic resonance imaging in differentiating osteoporotic benign and malignant vertebral marrow lesions.
Wadhawan BS; Kaur R; Kaur V; Jirankali V; Singh N; Jindal R
Pol J Radiol; 2021; 86():e468-e473. PubMed ID: 34567292
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted MR imaging for differentiation of benign and malignant musculoskeletal tumours at 3 T.
Lim HK; Jee WH; Jung JY; Paek MY; Kim I; Jung CK; Chung YG
Br J Radiol; 2018 Feb; 91(1082):20170636. PubMed ID: 29144153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
